Search for Clinical Trial Results
Hepatorenal Syndrome - 27 Studies Found
Status | Study |
Active, not recruiting |
Study Name: Treatment of Hepatorenal Syndrome With Terlipressin Infusion Adjusted to Hemodynamic Response Condition:
Date: 2012-02-09 Interventions: Drug: Terlipressin and albumin Terlipressin dose: 2mg/24h, |
Recruiting |
Study Name: The Effect of Terlipressin in the Prevention of Type 2 Hepatorenal Syndrome by Improving Mean Arterial Pressure Condition: Hepatorenal Syndrome Date: 2015-07-01 Interventions: Drug: Terlipressin |
Suspended |
Study Name: Treatment of Hepatorenal Syndrome With Terlipressin Plus Albumin vs Albumin Condition:
Date: 2006-02-03 Interventions: Drug: terlipressin |
Recruiting |
Study Name: A Study To Confirm Efficacy and Safety of Terlipressin in HRS Type 1 Condition: Hepatorenal Syndrome Date: 2016-05-10 Interventions:
|
Terminated |
Study Name: Terlipressin + Albumin Versus Midodrine + Octreotide in the Treatment of Hepatorenal Syndrome Condition:
Date: 2008-08-26 Interventions:
|
Terminated |
Study Name: Terlipressin Given As I.V. Boluses Versus Terlipressin Given As Continuous Intravenous Infusion In Patients With Cirrhosis And Type 1 Hepatorenal Syndrome Condition:
Date: 2008-08-26 Interventions:
|
Completed |
Study Name: Plasma and Hemodynamic Markers During Hepatectomy Condition: Hepatorenal Syndrome, Liver Regeneration Date: 2012-10-02 Interventions: Procedure: Liver resection Liver resection of patient with neoplastic hepatic tumors |
Terminated |
Study Name: Role Of Angiogenic Factors In The Development Of Hepatorenal Syndrome Condition:
|
Completed |
Study Name: TYPE 2 HEPATORENAL SYNDROME Condition: Safety and Efficacy of Terlipressin and Noradrenaline and Predictive Factors of Response in Type 2 HRS Date: 2012-06-28 Interventions:
|
Completed |
Study Name: A Placebo-Controlled, Double-Blind Study to Confirm the Reversal of Hepatorenal Syndrome Type 1 With Terlipressin Condition: HRS Date: 2010-06-11 Interventions:
|